Alamar Biosciences, Inc.
ALMRDrugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
No drugs found in this phase.
Alzheimer's disease detection and staging
1 drug in this indication
Alzheimer's Disease diagnostic
1 drug in this indication
Alzheimer's disease
1 drug in this indication
Alzheimer's Disease diagnostics
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
When is Alamar Biosciences, Inc.'s next FDA catalyst?→
Alamar Biosciences, Inc.'s (ALMR) next tracked catalyst is a Earnings expected November 9, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ALMR biotech catalysts?→
Add ALMR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Alamar Biosciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.